Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.
2.

Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trial.

Himmelmann B, Himmelmann A, Furrer K, Halter J, Schanz U.

Bone Marrow Transplant. 2002 Oct;30(8):491-6.

PMID:
12379887
[PubMed - indexed for MEDLINE]
Free Article
3.

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al.

Blood. 1995 Jun 15;85(12):3452-6.

PMID:
7540062
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H.

Bone Marrow Transplant. 2001 Mar;27(5):499-505.

PMID:
11313683
[PubMed - indexed for MEDLINE]
Free Article
6.

Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.

Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Armitage JO, Kessinger A.

J Clin Oncol. 1997 Apr;15(4):1608-16.

PMID:
9193360
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.

Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404.

PMID:
15148493
[PubMed - indexed for MEDLINE]
9.

Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study.

Torres Gómez A, Jimenez MA, Alvarez MA, Rodriguez A, Martin C, Garcia MJ, Flores R, Sanchez J, de la Torre MJ, Herrera C, et al.

Ann Hematol. 1995 Aug;71(2):65-70.

PMID:
7544628
[PubMed - indexed for MEDLINE]
10.

Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.

Isola L, Scigliano E, Fruchtman S.

Biol Blood Marrow Transplant. 2000;6(4A):428-33.

PMID:
10975511
[PubMed - indexed for MEDLINE]
11.

[A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].

Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.

Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1306-9. Chinese.

PMID:
12509932
[PubMed - indexed for MEDLINE]
12.

Optimal timing (Preemptive versus supportive) of granulocyte colony-stimulating factor administration following high-dose cyclophosphamide.

Koumakis G, Vassilomanolakis M, Barbounis V, Hatzichristou E, Demiri S, Plataniotis G, Pamouktsoglou F, Efremidis AP.

Oncology. 1999;56(1):28-35.

PMID:
9885374
[PubMed - indexed for MEDLINE]
13.

Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.

Lee SJ, Weller E, Alyea EP, Ritz J, Soiffer RJ.

Blood. 1998 Oct 15;92(8):2725-9.

PMID:
9763556
[PubMed - indexed for MEDLINE]
Free Article
14.

Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors.

Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R, Finke J.

Bone Marrow Transplant. 1999 May;23(10):983-90.

PMID:
10373062
[PubMed - indexed for MEDLINE]
Free Article
15.

Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients.

Couban S, Messner HA, Andreou P, Egan B, Price S, Tinker L, Meharchand J, Forrest DL, Lipton J.

Biol Blood Marrow Transplant. 2000;6(4A):422-7.

PMID:
10975510
[PubMed - indexed for MEDLINE]
16.

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.

Hofmann WK, Seipelt G, Langenhan S, Reutzel R, Schott D, Schoeffski O, Illiger HJ, Hartmann F, Balleisen L, Franke A, Fiedler F, Huber C, Rasche H, Bergmann L, Ganser A, Pott C, Pasold R, Rudolph C, Ottmann OG, Gökbuget N, Hoelzer D.

Ann Hematol. 2002 Oct;81(10):570-4. Epub 2002 Oct 17.

PMID:
12424538
[PubMed - indexed for MEDLINE]
17.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.

J Clin Oncol. 2004 Feb 1;22(3):416-23. Epub 2003 Dec 22.

PMID:
14691124
[PubMed - indexed for MEDLINE]
Free Article
18.

Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.

Vannucchi AM, Bosi A, Ieri A, Guidi S, Saccardi R, Lombardini L, Linari S, Laszlo D, Longo G, Rossi-Ferrini P.

Bone Marrow Transplant. 1996 Apr;17(4):527-31.

PMID:
8722349
[PubMed - indexed for MEDLINE]
19.

Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation.

Lee KH, Lee JH, Choi SJ, Kim S, Lee JS, Kim SH, Kim WK.

Bone Marrow Transplant. 1999 Sep;24(6):591-9.

PMID:
10490723
[PubMed - indexed for MEDLINE]
Free Article
20.

Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.

Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.

Haematologica. 1999 Nov;84(11):1016-23.

PMID:
10553163
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk